Revenue
Cost
Profit
| Item | Category | Value | YoY |
|---|
| Item | Category | Value | YoY |
|---|---|---|---|
| Property, plant and equipment, gross | assets | 513.59M | |
| Accounts and other receivables, net | assets | 93.70M | |
| Inventories | assets | 84.08M | |
| Cash and cash equivalents | assets | 15.61M | |
| Prepaid expenses and other | assets | 9.88M | |
| Accumulated depreciation, depletion and amortization, property, plant, and equipment | assets | 380.51M | |
| Total current assets | assets | 203.27M | |
| Net property, plant and equipment | assets | 133.08M | |
| Deferred income taxes | assets | 25.62M | |
| Goodwill | assets | 22.45M | |
| Right-of-use leased assets | assets | 12.22M | |
| Intangible assets, net (excluding goodwill) | assets | 5.13M | |
| Other assets | assets | 1.88M | |
| Total | assets | 403.64M | |
| Total liabilities | liabilities | 179.85M | |
| Total shareholders’ equity | equity | 223.79M | |
| Common stock, held-in-trust | equity | 2.23M | |
| Accumulated other comprehensive (income) loss, defined benefit plan, after tax | equity | 281000 | |
| Total current liabilities | liabilities | 118.34M | |
| Abl revolving facility | liabilities | 45.80M | |
| Lease liability, long-term | liabilities | 10.44M | |
| Other non-current liabilities | liabilities | 3.97M | |
| Pension and other postretirement benefit obligations, net | liabilities | 1.29M | |
| Aggregate | equity | 226.31M | |
| Accounts payable | liabilities | 96.44M | |
| Accrued expenses | liabilities | 18.41M | |
| Lease liability, short-term | liabilities | 2.14M | |
| Income taxes payable | liabilities | 842000 | |
| Short-term debt | liabilities | 506000 | |
| Retained earnings | equity | 152.55M | |
| Common stock, no par value (authorized shares 150,000,000, issued and outstanding 34,995,206 shares at march 31, 2026 and 34,737,534 shares at december 31, 2025) | equity | 65.94M | |
| Foreign currency translation adjustment | equity | 5.89M | |
| Gain (loss) on derivative financial instruments | equity | 1.92M |
| Item | Value |
|---|---|
| Accounts payable and accrued expenses | 13.96M |
| Increase (decrease) in prepaid expense and other assets | 6.74M |
| Net income (loss) | 5.66M |
| Depreciation | 4.86M |
| Other, net | 624000 |
| Reduction of right-of-use leased assets | 543000 |
| Stock-based compensation expense | 454000 |
| Amortization of identifiable intangibles | 440000 |
| Increase (decrease) in income taxes receivable | 436000 |
| Deferred income taxes | 429000 |
| Accrued pension and post-retirement benefits | 39000 |
| Payment for pension and other postretirement benefits | -26000 |
| Gain (loss) on disposition of business | -565000 |
| Short-term lease payments | -640000 |
| Increase (decrease) in accounts and other receivables | -11.89M |
| Increase (decrease) in inventories | -19.11M |
| Item | Value |
|---|---|
| Proceeds from the sale of terphane | 565000 |
| Payments to acquire property, plant, and equipment | -5.14M |
| Item | Value |
|---|---|
| Proceeds from long-term lines of credit | 49.95M |
| Repayments of long-term lines of credit | -38.70M |
| Item | Value |
|---|---|
| Cash and cash equivalents, beginning of period | 6.73M |
| Cash and cash equivalents, end of period | 15.61M |
Instantly decode complex 10-K and 10-Q data. Explore interactive Sankey diagrams for income and balance sheets, and intuitive waterfall charts for cash flows.
Search for a company and select a report on the left panel.
Request Stock Support